FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip Barter

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Rabbits

Co-author Network

Publications

TOP 3
Kwok Leung Ong; Philip J Barter; Bernard M Y Cheung; Ben J Wu; Kerry-Anne Rye
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008.
Ben J Wu; Sudichhya Shrestha; Philip J Barter; Kang Chen; Kwok L Ong; Kerry-Anne Rye
High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1.
Kwok Leung Ong; Kerry-Anne Rye; David R Sullivan; Aimin Xu; Philip J Barter; Chris Brown; Alicia J Jenkins; Anthony C Keech; Rachel O'Connell
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip Barter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kwok Leung Ong; Philip J Barter; Bernard M Y Cheung; Ben J Wu; Kerry-Anne Rye
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008.
Annals of epidemiology 2013;23(2):80-6.
2013: Ben J Wu; Sudichhya Shrestha; Philip J Barter; Kang Chen; Kwok L Ong; Kerry-Anne Rye
High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1.
Circulation research 2013;112(2):278-88.
2012: Kwok Leung Ong; Kerry-Anne Rye; David R Sullivan; Aimin Xu; Philip J Barter; Chris Brown; Alicia J Jenkins; Anthony C Keech; Rachel O'Connell
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2012;97(12):4701-8.
2012: Philip J Barter; Mohan S Beltangady; S Matthijs Boekholdt; David A DeMicco; William T Duggan; John J P Kastelein; William C Ports; Kerry-Anne Rye; Charles L Shear
Relationship between atorvastatin dose and the harm caused by torcetrapib.
Journal of lipid research 2012;53(11):2436-42.
2012: Kerry-Anne Rye; Philip J Barter
Predictive value of different HDL particles for the protection against or risk of coronary heart disease.
Biochimica et biophysica acta 2012;1821(3):473-80.
2011: Kwok Leung Ong; Philip J Barter; Bernard M Y Cheung; Ben J Wu; Kerry-Anne Rye
Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008.
Atherosclerosis 2011;219(2):728-33.
2011: Philip J Barter; S Matthijs Boekholdt; Andrei Breazna; Kerry-Anne Rye; Jean-Claude Tardif; David D Waters; John J P Kastelein
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
Circulation 2011;124(5):555-62.
2011: Belinda A Di Bartolo; Alison K Heather; Stephen J Nicholls; Kerry-Anne Rye; Shisan Bao; Philip J Barter; Christina Bursill
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Atherosclerosis 2011;217(2):395-400.
2011: Philip J Barter
The causes and consequences of low levels of high density lipoproteins in patients with diabetes.
Diabetes & metabolism journal 2011;35(2):101-6.
2010: Philip J Barter
The relationship between cholesteryl ester transfer protein and cardiovascular risk.
Clinical chemistry 2010;56(10):1547-9.
2010: Sanjay Patel; Belinda A Di Bartolo; Shirley Nakhla; Alison K Heather; Todd W Mitchell; Wendy Jessup; David S Celermajer; Philip J Barter; Kerry-Anne Rye
Anti-inflammatory effects of apolipoprotein A-I in the rabbit.
Atherosclerosis 2010;212(2):392-7.
2010: Philip J Barter; Gunnar Brandrup-Wognsen; michael palmer; Stephen J Nicholls
Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database.
Journal of lipid research 2010;51(6):1546-53.
2010: Ben J Wu; Ling Yan; Francesca Charlton; Paul Witting; Philip J Barter; Kerry-Anne Rye
Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(5):968-75.
2010: Fatiha Tabet; Alan T Remaley; Aude I Segaliny; Jonathan Millet; Ling Yan; Shirley Nakhla; Philip J Barter; Kerry-Anne Rye; Gilles Lambert
The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(2):246-52.
2009: Sanjay Patel; Rajesh Puranik; Shirley Nakhla; Pia Lundman; Roland Stocker; Xiao S Wang; Gilles Lambert; Kerry-Anne Rye; Philip J Barter; Stephen J Nicholls; David S Celermajer
Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins.
Atherosclerosis 2009;204(2):424-8.
2009: Kerry-Anne Rye; Christina A Bursill; Gilles Lambert; Fatiha Tabet; Philip J Barter
The metabolism and anti-atherogenic properties of HDL.
Journal of lipid research 2009;50 Suppl():S195-200.
2008: Kerry-Anne Rye; Philip J Barter
Antiinflammatory actions of HDL: a new insight.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(11):1890-1.
2008: E Nobécourt; J Zeng; M J Davies; B E Brown; S Yadav; Philip J Barter; Kerry-Anne Rye
Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
Diabetologia 2008;51(6):1008-17.
2008: Gilles Lambert; nicolas ancellin; Francesca Charlton; Daniel Comas; Julia Pilot; Anthony Keech; Sanjay Patel; David R Sullivan; Jeffrey S Cohn; Kerry-Anne Rye; Philip J Barter
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment.
Clinical chemistry 2008;54(6):1038-45.
2008: Nongnuch Settasatian; Philip J Barter; Kerry-Anne Rye
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
Journal of lipid research 2008;49(1):115-26.
2008: Philip J Barter; Kerry-Anne Rye
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?
Arteriosclerosis, thrombosis, and vascular biology 2008;28(1):39-46.
2008: Rajesh Puranik; Shisan Bao; Estelle Nobecourt; Stephen J Nicholls; Gregory J Dusting; Philip J Barter; David S Celermajer; Kerry-Anne Rye
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo.
Atherosclerosis 2008;196(1):240-7.
2007: Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Effects of torcetrapib in patients at high risk for coronary events.
The New England journal of medicine 2007;357(21):2109-22.
2007: Philip J Barter; Antonio M Gotto; John C LaRosa; Jaman Maroni; Michael Szarek; Scott M Grundy; John J P Kastelein; Vera Bittner; Jean-Charles Fruchart
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
The New England journal of medicine 2007;357(13):1301-10.
2007: Danielle Skropeta; Chatri Settasatian; Monica R McMahon; Kate Shearston; Daniela Caiazza; Kristine C McGrath; Weijun Jin; Daniel J Rader; Philip J Barter; Kerry-Anne Rye
N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins.
Journal of lipid research 2007;48(9):2047-57.
2007: Philip J Barter; Charles L Shear
Aggressive management of obesity in children and young adults: the known challenges and potential opportunities.
Clinical pharmacology and therapeutics 2007;81(5):627-30.
2007: John J P Kastelein; Sander I van Leuven; Leslie Burgess; Gregory Evans; Jan Albert Kuivenhoven; Philip J Barter; James H Revkin; Diederick Grobbee; Ward A Riley; Charles L Shear; William T Duggan; Michiel Bots
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
The New England journal of medicine 2007;356(16):1620-30.
2007: E Nobecourt; M J Davies; B E Brown; Linda K Curtiss; D J Bonnet; F Charlton; Andrzej Januszewski; Alicia J Jenkins; Philip J Barter; Kerry-Anne Rye
The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
Diabetologia 2007;50(3):643-53.
2006: David D Waters; John C LaRosa; Philip J Barter; Jean-Charles Fruchart; Antonio M Gotto; Roddy Carter; Andrei Breazna; John J P Kastelein; Scott M Grundy
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
Journal of the American College of Cardiology 2006;48(9):1793-9.
2006: Prakash Deedwania; Philip J Barter; Rafael Carmena; Jean-Charles Fruchart; Scott M Grundy; Steven M Haffner; John J P Kastelein; John C LaRosa; Holly Schachner; James Shepherd; David D Waters
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Lancet 2006;368(9539):919-28.
2006: Stephen J Nicholls; Pia Lundman; Jason A Harmer; Belinda Cutri; Kaye A Griffiths; Kerry-Anne Rye; Philip J Barter; David S Celermajer
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function.
Journal of the American College of Cardiology 2006;48(4):715-20.
2006: Philip J Barter; Kerry-Anne Rye
Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.
Current opinion in lipidology 2006;17(4):399-403.
2006: James Shepherd; Philip J Barter; Rafael Carmena; Prakash Deedwania; Jean-Charles Fruchart; Steven M Haffner; Judith Hsia; Andrei Breazna; John C LaRosa; Scott Grundy; David Waters
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
Diabetes care 2006;29(6):1220-6.
2006: Philip J Barter; Kerry-Anne Rye
The rationale for using apoA-I as a clinical marker of cardiovascular risk.
Journal of internal medicine 2006;259(5):447-54.
2006: Kerry-Anne Rye; Richard Bright; Maria Psaltis; Philip J Barter
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.
Journal of lipid research 2006;47(5):1025-36.
2006: Patrick Kee; Daniela Caiazza; Kerry-Anne Rye; Hugh Barrett; L A Morehouse; Philip J Barter
Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(4):884-90.
2006: Philip J Barter; C M Ballantyne; R Carmena; Manuel Castro Cabezas; M John Chapman; P Couture; J de Graaf; P N Durrington; O Faergeman; J Frohlich; Curt D Furberg; C Gagne; Steven M Haffner; S E Humphries; Ingmar Jungner; R M Krauss; Peter O Kwiterovich; S Marcovina; C J Packard; Thomas A Pearson; K Srinath Reddy; Robert S Rosenson; Nizal Sarrafzadegan; Allan D Sniderman; A F Stalenhoef; E Stein; P J Talmud; A M Tonkin; Göran Walldius; K M S Williams
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Journal of internal medicine 2006;259(3):247-58.
2006: Neil J Hime; Kate J Drew; Kevin Wee; Philip J Barter; Kerry-Anne Rye
Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.
Journal of lipid research 2006;47(1):115-22.
2005: Stephen J Nicholls; Belinda Cutri; Stephen G Worthley; Patrick Kee; Kerry-Anne Rye; Shisan Bao; Philip J Barter
Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(11):2416-21.
2005: Stephen J Nicholls; Kerry-Anne Rye; Philip J Barter
High-density lipoproteins as therapeutic targets.
Current opinion in lipidology 2005;16(3):345-9.
2005: John C LaRosa; Scott M Grundy; David D Waters; Charles L Shear; Philip J Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
The New England journal of medicine 2005;352(14):1425-35.
2005: Stephen J Nicholls; Gregory J Dusting; Belinda Cutri; Shisan Bao; Grant R Drummond; Kerry-Anne Rye; Philip J Barter
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits.
Circulation 2005;111(12):1543-50.
2004: Neil J Hime; Kate J Drew; Chris Hahn; Philip J Barter; Kerry-Anne Rye
Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner.
Biochemistry 2004;43(38):12306-14.
2004: Kerry-Anne Rye; Philip J Barter
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):421-8.
2003: MyNgan Duong; Maria Psaltis; Daniel J Rader; Dawn Marchadier; Philip J Barter; Kerry-Anne Rye
Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.
Biochemistry 2003;42(46):13778-85.
2003: Philip J Barter
Introduction. Lipids, inflammation and CVD--understanding the basics to break the atherosclerosis cycle.
International journal of clinical practice. Supplement 2003;(137):2-4.
2003: Kerry-Anne Rye; Kevin Wee; Linda K Curtiss; David J Bonnet; Philip J Barter
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
The Journal of biological chemistry 2003;278(25):22530-6.
2003: Philip J Barter; John Kastelein; Alistair Nunn; Richard F D Hobbs
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.
Atherosclerosis 2003;168(2):195-211.
2003: Philip J Barter; H Bryan Brewer; M John Chapman; Charles H Hennekens; Daniel J Rader; Alan R Tall
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(2):160-7.
2002: Patrick Kee; Kerry-Anne Rye; John L Taylor; Hugh Barrett; Philip J Barter
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1912-7.
2002: Kerry-Anne Rye; MyNgan Duong; Maria Psaltis; Linda K Curtiss; David J Bonnet; Roland Stocker; Philip J Barter
Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.
Biochemistry 2002;41(41):12538-45.
2002: Philip J Barter
Treatment of dyslipidaemia in high-risk patients: too little, too late.
International journal of clinical practice. Supplement 2002;(130):15-9.
2002: Philip J Barter; Paul W Baker; Kerry-Anne Rye
Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells.
Current opinion in lipidology 2002;13(3):285-8.
2001: Neil J Hime; Philip J Barter; Kerry-Anne Rye
Evidence that apolipoprotein A-I facilitates hepatic lipase-mediated phospholipid hydrolysis in reconstituted HDL containing apolipoprotein A-II.
Biochemistry 2001;40(18):5496-505.
2001: D Ashby; J Gamble; Mathew A Vadas; N Fidge; S Siggins; Kerry-Anne Rye; Philip J Barter
Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression.
Atherosclerosis 2001;154(1):113-21.
2000: Paul W Baker; Kerry-Anne Rye; Jennifer R Gamble; Mathew A Vadas; Philip J Barter
Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression.
Journal of lipid research 2000;41(8):1261-7.
2000: Philip J Barter; R C O'Brien
Achievement of target plasma cholesterol levels in hypercholesterolaemic patients being treated in general practice.
Atherosclerosis 2000;149(1):199-205.
1999: Pu Xia; Mathew A Vadas; Kerry-Anne Rye; Philip J Barter; Jennifer R Gamble
High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL.
The Journal of biological chemistry 1999;274(46):33143-7.
1999: Kerry-Anne Rye; M A Clay; Philip J Barter
Remodelling of high density lipoproteins by plasma factors.
Atherosclerosis 1999;145(2):227-38.
1999: Paul W Baker; Kerry-Anne Rye; Jennifer R Gamble; Mathew A Vadas; Philip J Barter
Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.
Journal of lipid research 1999;40(2):345-53.
1998: Pu Xia; Jennifer R Gamble; Kerry-Anne Rye; Lijun Wang; Charles S T Hii; Peter N Cockerill; Yeesim Khew-Goodall; Andrew G Bert; Philip J Barter; Mathew A Vadas
Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14196-201.
1998: Neil J Hime; Philip J Barter; Kerry-Anne Rye
The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol.
The Journal of biological chemistry 1998;273(42):27191-8.
1998: Kerry-Anne Rye; M Jauhiainen; Philip J Barter; C Ehnholm
Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein.
Journal of lipid research 1998;39(3):613-22.
1997: Philip J Barter
Inhibition of endothelial cell adhesion molecule expression by high density lipoproteins.
Clinical and experimental pharmacology & physiology 1997;24(3-4):286-7.
1997: Kerry-Anne Rye; Neil J Hime; Philip J Barter
Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion.
The Journal of biological chemistry 1997;272(7):3953-60.
1996: H Q Liang; Kerry-Anne Rye; Philip J Barter
Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.
Journal of lipid research 1996;37(9):1962-70.
1996: M A Clay; Philip J Barter
Formation of new HDL particles from lipid-free apolipoprotein A-I.
Journal of lipid research 1996;37(8):1722-32.
1996: Philip J Barter; Kerry-Anne Rye
Molecular mechanisms of reverse cholesterol transport.
Current opinion in lipidology 1996;7(2):82-7.
1996: Philip J Barter; Kerry-Anne Rye
High density lipoproteins and coronary heart disease.
Atherosclerosis 1996;121(1):1-12.
1996: Kerry-Anne Rye; Neil J Hime; Philip J Barter
The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins.
The Journal of biological chemistry 1996;271(8):4243-50.
1995: H Q Liang; Kerry-Anne Rye; Philip J Barter
Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools.
Biochimica et biophysica acta 1995;1257(1):31-7.
1995: Kerry-Anne Rye; Neil J Hime; Philip J Barter
The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins.
The Journal of biological chemistry 1995;270(1):189-96.
1994: Philip J Barter; Kerry-Anne Rye
Cholesteryl ester transfer protein: its role in plasma lipid transport.
Clinical and experimental pharmacology & physiology 1994;21(9):663-72.
1994: H Q Liang; Kerry-Anne Rye; Philip J Barter
Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins.
Journal of lipid research 1994;35(7):1187-99.
1994: Kerry-Anne Rye; Philip J Barter
The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins.
The Journal of biological chemistry 1994;269(14):10298-303.
1993: Philip J Barter; O V Rajaram; H Q Liang; Kerry-Anne Rye
Relationship between the size and phospholipid content of low-density lipoproteins.
Biochimica et biophysica acta 1993;1166(1):135-7.
1993: D L Ebert; R J Warren; Philip J Barter; A Mitchell
Infusion of atherogenic lipoprotein particles increases hepatic lipase activity in the rabbit.
Journal of lipid research 1993;34(1):89-94.
1992: H H Newnham; Philip J Barter
Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase.
Biochimica et biophysica acta 1992;1125(3):297-304.
1991: R J Warren; D L Ebert; Philip J Barter; A Mitchell
The regulation of hepatic lipase and cholesteryl ester transfer protein activity in the cholesterol fed rabbit.
Biochimica et biophysica acta 1991;1086(3):354-8.
1991: R J Warren; D L Ebert; A Mitchell; Philip J Barter
Rabbit hepatic lipase cDNA sequence: low activity is associated with low messenger RNA levels.
Journal of lipid research 1991;32(8):1333-9.
1991: L Lagrost; Philip J Barter
Effects of various non-esterified fatty acids on the particle size redistribution of high density lipoproteins induced by the human cholesteryl ester transfer protein.
Biochimica et biophysica acta 1991;1082(2):204-10.
1991: B Meyer; E Kecorius; Philip J Barter; NH Fidge; T Tetaz
Application of reversed-phase high-performance liquid chromatography to the separation of apolipoproteins A-IV, A-I and E from rat high-density lipoprotein.
Journal of chromatography 1991;540(1-2):386-91.
1991: M A Clay; H H Newnham; Philip J Barter
Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(2):415-22.
1991: Philip J Barter
Role of non-esterified fatty acids in regulating plasma cholesterol transport.
Clinical and experimental pharmacology & physiology 1991;18(2):77-9.
1991: Philip J Barter; L B Chang; O V Rajaram
Factors regulating the distribution of cholesterol between LDL and HDL.
Advances in experimental medicine and biology 1991;285():59-64.
1990: Philip J Barter; L B Chang; O V Rajaram
Sodium oleate dissociates the heteroexchange of cholesteryl esters and triacylglycerol between HDL and triacylglycerol-rich lipoproteins.
Biochimica et biophysica acta 1990;1047(3):294-7.
1990: Philip J Barter; L B Chang; O V Rajaram
Sodium oleate promotes a redistribution of cholesteryl esters from high to low density lipoproteins.
Atherosclerosis 1990;84(1):13-24.
1990: Philip J Barter; L B Chang; H H Newnham; Kerry-Anne Rye; O V Rajaram
The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins.
Biochimica et biophysica acta 1990;1045(1):81-9.
1990: H H Newnham; G J Hopkins; S Devlin; Philip J Barter
Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasma.
Atherosclerosis 1990;82(3):167-76.
1990: H H Newnham; Philip J Barter
Synergistic effects of lipid transfers and hepatic lipase in the formation of very small high-density lipoproteins during incubation of human plasma.
Biochimica et biophysica acta 1990;1044(1):57-64.
1990: M A Clay; Kerry-Anne Rye; Philip J Barter
Evidence in vitro that hepatic lipase reduces the concentration of apolipoprotein A-I in rabbit high-density lipoproteins.
Biochimica et biophysica acta 1990;1044(1):50-6.
1989: B J Meyer; Y C Ha; Philip J Barter
Effects of experimental hypothyroidism on the distribution of lipids and lipoproteins in the plasma of rats.
Biochimica et biophysica acta 1989;1004(1):73-9.
1989: M A Clay; G J Hopkins; C P Ehnholm; Philip J Barter
The rabbit as an animal model of hepatic lipase deficiency.
Biochimica et biophysica acta 1989;1002(2):173-81.
1989: G J Hopkins; Philip J Barter
Apolipoprotein A-I inhibits transformation of high density lipoprotein subpopulations during incubation of human plasma.
Atherosclerosis 1989;75(1):73-82.
1988: Philip J Barter; O V Rajaram; L B Chang; Kerry-Anne Rye; P Gambert; L Lagrost; C Ehnholm; NH Fidge
Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator.
The Biochemical journal 1988;254(1):179-84.
1987: Philip J Barter; G J Hopkins; O V Rajaram
Enzymes involved in plasma cholesterol transport.
Baillière's clinical endocrinology and metabolism 1987;1(3):623-38.
1986: O V Rajaram; Philip J Barter
Increases in the particle size of high-density lipoproteins induced by purified lecithin: cholesterol acyltransferase: effect of low-density lipoproteins.
Biochimica et biophysica acta 1986;877(3):406-14.
1985: L B Chang; G J Hopkins; Philip J Barter
Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects.
Atherosclerosis 1985;56(1):61-70.
1985: O V Rajaram; Philip J Barter
Reactivity of human lipoproteins with purified lecithin: cholesterol acyltransferase during incubations in vitro.
Biochimica et biophysica acta 1985;835(1):41-9.
1985: Y C Ha; L B Chang; Philip J Barter
Effects of injecting exogenous lipid transfer protein into rats.
Biochimica et biophysica acta 1985;833(2):203-10.
1985: G J Hopkins; L B Chang; Philip J Barter
Role of lipid transfers in the formation of a subpopulation of small high density lipoproteins.
Journal of lipid research 1985;26(2):218-29.
1984: Y C Ha; L B Chang; Philip J Barter
Incubation of human lipid transfer protein with plasma from normal-fed and cholesterol-fed rats: effect on the distribution of constituents between lipoprotein fractions.
Comparative biochemistry and physiology. B, Comparative biochemistry 1984;78(3):675-82.
1980: O V Rajaram; Philip J Barter
Influence of lipoprotein concentration on the exchanges of triacylglycerol between rabbit plasma low density and high density lipoproteins.
Biochimica et biophysica acta 1980;620(3):483-8.
1980: O V Rajaram; G H White; Philip J Barter
Partial purification and characterization of a triacylglycerol-transfer protein from rabbit serum.
Biochimica et biophysica acta 1980;617(3):383-92.
1980: O V Rajaram; M G Clark; Philip J Barter
Differences in the metabolism of very-low-density lipoproteins by isolated beating-heart cells and the isolated perfused rat heart. Evidence for collagenase-released extracellular lipoprotein lipase.
The Biochemical journal 1980;186(2):431-8.